CA-VERIMATRIX
20.4.2022 17:47:11 CEST | Business Wire | Press release
Regulatory News:
Verimatrix , (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Megacable , one of Mexico’s largest telecommunications companies, selected a suite of Verimatrix products and technologies to fortify its enterprise defenses; Verimatrix XTD (Extended Threat Defense), Streamkeeper Watermarking , Streamkeeper Edge Authenticator and App Shield .
Megacable, the first company in Mexico to offer quadruple-play services (cable television, broadband internet, fixed telephony and mobile telephony), has millions of subscribers using the media company’s apps running on unmanaged devices. The company was well aware that extended endpoints at the app level could be weaponized at any time by attackers to attack their enterprise defenses, and they wanted to find a way to expand their defense beyond the traditional perimeter. Additionally, it’s no secret that the media & entertainment industry is seeing a rise in industrial-scale piracy attacks on content distribution networks, and they selected Verimatrix specifically for its distinguished reputation in both threat defense and anti-piracy.
Megacable products set to use Verimatrix threat defense and anti-piracy solutions include the Xview+ app, Android TV set-top boxes, select Megacable.com.mx payment/financial services, as well as other internal Megacable apps.
Hackers are continually looking for new ways to infiltrate enterprise security walls and Verimatrix XTD consistently identifies and closes vulnerabilities. Verimatrix XTD is an enterprise SaaS solution that will monitor Megacable’s mobile apps and devices connected to their cloud services.
Verimatrix XTD’s features include:
- Shielding Apps – With self-defending mobile application shielding, Verimatrix provides organizations with layers of protections such as obfuscation, environmental checks and anti-tamper, plus 24/7 monitoring with immediate detection when an app is under attack with remote shut-down capability.
- Unmanaged Device Telemetry – Protection from unmanaged devices at the endpoint, such as set-top box receivers, IoT and medical devices, by gaining real-time, continuous threat intelligence utilizing Verimatrix’s zero-code telemetry technology.
- Monitoring and Early Detection – Better understand the threat profile of your installed base of users, and drill down into the risk score of an individual app instance, with real-time notifications of high-risk events to uncover hidden dangers in your enterprise security wall.
- Attack Pattern Detection and Prediction – Comprehensive, predictive analysis of cyber threats based on large data sets, artificial intelligence (AI) and machine learning (ML), to recognize patterns, making future predictions to benefit the enterprise.
Having used Verimatrix IPTV and DVB Hybrid content security solutions since 2012, Megacable’s work with Verimatrix is also expanded with the deployment of Watermarking and Edge Authenticator anti-piracy solutions. The unique deployment of Streamkeeper zero-code injection technology into select Megacable set-top boxes is a first for both companies. The process will protect access to the Content Security Network (CDN) without the need for cumbersome, time consuming or expensive integrations, meeting stringent requirements from major studios that require it for 4K Ultra HD content. Megacable may add additional Verimatrix Streamkeeper services to its portfolio of anti-piracy countermeasures in the future.
“Megacable already enjoys robust network security, but by adding Verimatrix XTD and Streamkeeper anti-piracy technologies, we’re creating an even more formible security posture for our company, our content and our customers,” said Gerardo Seifert Arriola, Chief Marketing Officer at Megacable. “We’re pleased to continue working with Verimatrix to provide an excellent user experience while also deploying the latest in security technology to maintain our stance as the regional leader in our industry.”
“Megacable has taken a bold step forward by adding threat defense and anti-piracy technology to their enterprise security stack,” said Asaf Ashkenazi , Chief Operating Officer and President at Verimatrix. “Megacable is now our largest customer to date to commit to deploying Verimatrix Streamkeeper and Verimatrix XTD solutions. The alliance underscores our goal to provide proactive cybersecurity and anti-piracy countermeasures that fortify operators against threats of today and the unforeseen dangers of tomorrow. We’re pleased to continue working with Megacable to provide unique and innovative solutions that boost protections and also help ensure exceptional user experiences no matter how content is accessed.”
About Megacable
Megacable Holdings S.A.B. de C.V. (BMV: MEGA.CPO) is one of the largest telecommunications companies in Mexico and Latin America. It carries out operations in 28 states of the country, with a presence in 400 locations. As of December 31, 2021, it has about 4.2 million unique subscribers, including more than 3.8 million internet subscribers, more than 3.5 million video users and more than 3 million fixed telephony customers. It offers its services through a network of nearly 66,000 kilometers, covering more than 9.5 million homes. Visit www.megacable.com.mx
.
About Verimatrix
Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220420005732/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
